Literature DB >> 16373251

Environment and systemic lupus erythematosus: an overview.

Piercarlo Sarzi-Puttini1, Fabiola Atzeni, Luca Iaccarino, Andrea Doria.   

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disease of unknown etiology that manifests as a pleomorphic systemic disease mainly affecting females. The variety of autoantibodies found in the serum of patients indicate that SLE is an autoimmune disease, but the mechanisms leading to the aberrant responses are not clearly understood although it is thought that a number of genetic and environmental factors may be involved. Environmental (or non-genetic) exposures could include infectious agents, chemicals or other compounds capable of modulating immune responses such as occupational/environmental pollutants or drugs, and behavioural factors such as smoking and diet. Environmental exposures may lead to the production of autoreactive T cells and autoantibodies, the stimulation of pro- and antiinflammatory cytokines, and target end-organ damage, but are not so convincing as agents causing SLE. Exposure to viruses increases antibody titres, but these may be the result of polyclonal B cell activation. The amount and timing of exposure to different environmental factors may play a significant and complex role in the pathogenesis of SLE and other autoimmune diseases. A better understanding of the etiopathogenetic mechanism of SLE is required in order to clarify the multiple interactions between environmental exposures and genetic factors.

Entities:  

Mesh:

Year:  2005        PMID: 16373251     DOI: 10.1080/08916930500285394

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  30 in total

1.  The involvement of T regulatory lymphocytes in a cohort of lupus nephritis patients: a pilot study.

Authors:  Antonella Afeltra; Antonietta Gigante; Domenico Paolo Emanuele Margiotta; Chiara Taffon; Rosario Cianci; Biagio Barbano; Marta Liberatori; Antonio Amoroso; Filippo Rossi Fanelli
Journal:  Intern Emerg Med       Date:  2015-02-27       Impact factor: 3.397

2.  Including gender in public health research.

Authors:  Susan P Phillips
Journal:  Public Health Rep       Date:  2011 Sep-Oct       Impact factor: 2.792

3.  TREX1 D18N mice fail to process erythroblast DNA resulting in inflammation and dysfunctional erythropoiesis.

Authors:  Stephen L Rego; Scott Harvey; Sean R Simpson; Wayne O Hemphill; Zachariah A McIver; Jason M Grayson; Fred W Perrino
Journal:  Autoimmunity       Date:  2018-11-13       Impact factor: 2.815

4.  Epigenetics in systemic lupus erythematosus: leading the way for specific therapeutic agents.

Authors:  Matlock A Jeffries; Amr H Sawalha
Journal:  Int J Clin Rheumtol       Date:  2011-08

Review 5.  Lupus and Epstein-Barr.

Authors:  Judith A James; Julie M Robertson
Journal:  Curr Opin Rheumatol       Date:  2012-07       Impact factor: 5.006

6.  Macrophages from lupus-prone MRL mice have a conditional signaling abnormality that leads to dysregulated expression of numerous genes.

Authors:  Angelika Antoni; Vimal A Patel; Hanli Fan; Daniel J Lee; Lee H Graham; Cristen L Rosch; Daniel S Spiegel; Joyce Rauch; Jerrold S Levine
Journal:  Immunogenetics       Date:  2011-01-13       Impact factor: 2.846

7.  XRCC1 Arg399Gln gene polymorphism and the risk of systemic lupus erythematosus in the Polish population.

Authors:  Teresa Warchoł; Adriana Mostowska; Margarita Lianeri; Jan K Lącki; Paweł P Jagodziński
Journal:  DNA Cell Biol       Date:  2011-06-17       Impact factor: 3.311

8.  Biomarkers in systemic lupus erythematosus: challenges and prospects for the future.

Authors:  Chau-Ching Liu; Amy H Kao; Susan Manzi; Joseph M Ahearn
Journal:  Ther Adv Musculoskelet Dis       Date:  2013-08       Impact factor: 5.346

Review 9.  Genetics of Lupus Nephritis: Clinical Implications.

Authors:  Melissa E Munroe; Judith A James
Journal:  Semin Nephrol       Date:  2015-09       Impact factor: 5.299

10.  Defective T-cell ERK signaling induces interferon-regulated gene expression and overexpression of methylation-sensitive genes similar to lupus patients.

Authors:  A H Sawalha; M Jeffries; R Webb; Q Lu; G Gorelik; D Ray; J Osban; N Knowlton; K Johnson; B Richardson
Journal:  Genes Immun       Date:  2008-06       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.